Flow Cytometer for NIDDK

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health within the Department of Health and Human Services, is procuring a high-performance flow cytometer instrument designed for high-speed, high-parameter analysis of cells with both spectral and conventional flow cytometry capabilities. The solicitation specifically identifies the ThermoFisher Scientific Attune Xenith Flow Cytometer as the required equipment, which must feature 6 spatially separated flat-top lasers, 51 fluorescence detectors, acoustic-focusing fluidics technology, and the ability to analyze particles ranging from 0.16 micrometers to 50 micrometers. The instrument will replace an outdated 2018 model currently limiting research to 10-14 color panels and must enable analysis of 40+ parameters per cell while supporting integration with single-cell RNA sequencing across 17 NIDDK laboratories. The government will evaluate proposals based on best value considering cost/price, past performance, delivery terms, and technical capability to meet specified requirements. Electronic submissions are due by 5:00 PM Eastern Time on September 21, 2025, to jacob.balenson@nih.gov.

This procurement does not utilize any set-aside designation and is open to all businesses, with a small business size standard of 1,000 employees under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing. No current incumbent contractors or specific award values are mentioned in the solicitation documents, though the procurement will be structured as a Firm Fixed-Price Purchase Order with payment processed as a lump sum according to NIH Invoice and Payment Provisions. The government anticipates delivery within 90 days after order receipt, with installation required at the Kidney Disease Branch in Building 10, Room 10S224 in Bethesda, Maryland. The procurement includes associated equipment such as SmartStart Xenith 3D, AB Assurance components, CytKick Max System, and training services to support the NIDDK Intramural Research Program's advanced cell analysis research capabilities.